Literature DB >> 23459282

Guidance for the discontinuation or switching of antidepressant therapies in adults.

Nikki R Ogle1, Shawn R Akkerman.   

Abstract

Antidepressants (ADs) are commonly used for the treatment of various psychological and other medical disorders. Patient response and regimen duration with individual agents varies, necessitating discontinuation (DC) and/or switching between ADs. However, withdrawal symptoms may occur upon DC of the AD, and clinical symptom control may be compromised if the change to a new AD agent is not initiated appropriately. The purpose of this evaluation was to review the available literature and resources to compile documented methods for discontinuing or changing AD regimens in the clinical setting into a single guidance document. The results of this evaluation have yielded both detailed and general recommendations for practitioners to use and consider in discontinuing an AD and making changes between AD agents. The information provided herein is intended to provide useful guidance for clinicians and other health care professionals in their management of patients discontinuing or switching between selected AD agents.

Entities:  

Keywords:  antidepressant; discontinuation; taper; withdrawal; withdrawal syndrome

Mesh:

Substances:

Year:  2013        PMID: 23459282     DOI: 10.1177/0897190012467210

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  9 in total

1.  Antidepressant discontinuation syndrome.

Authors:  Matthew Gabriel; Verinder Sharma
Journal:  CMAJ       Date:  2017-05-29       Impact factor: 8.262

2.  Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric Drugs.

Authors:  Eunkyung Jo; Myeonghan Ryu; Georgia Kenderova; Samuel So; Bryan Shapiro; Alexandra Papoutsaki; Daniel A Epstein
Journal:  Proc SIGCHI Conf Hum Factor Comput Syst       Date:  2022-04-29

3.  Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

Authors:  Chloe P O'Connell; Andrea N Goldstein-Piekarski; Charles B Nemeroff; Alan F Schatzberg; Charles Debattista; Tania Carrillo-Roa; Elisabeth B Binder; Boadie W Dunlop; W Edward Craighead; Helen S Mayberg; Leanne M Williams
Journal:  Am J Psychiatry       Date:  2017-12-15       Impact factor: 18.112

Review 4.  Early switching strategies in antidepressant non-responders: current evidence and future research directions.

Authors:  Paul A Kudlow; Roger S McIntyre; Raymond W Lam
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

Review 5.  A review of the management of antidepressant discontinuation symptoms.

Authors:  Emma Wilson; Malcolm Lader
Journal:  Ther Adv Psychopharmacol       Date:  2015-12

6.  Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.

Authors:  Michael P Hengartner; Lukas Schulthess; Anders Sorensen; Adele Framer
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-24

7.  Mobile phone applications to support psychotropic tapering: a scoping review protocol.

Authors:  Miriam Boland; Agnes Higgins; Gavin Doherty; Greg Sheaf; Adele Framer; Cathal Cadogan
Journal:  HRB Open Res       Date:  2022-08-19

8.  Is depression the contraindication of anterior cervical decompression and fusion for cervical spondylosis?

Authors:  Xiaolu Chen; Xiao Li; Yu Gan; Ying Lu; Yu Tian; Yixiao Fu; Hanjie Yang; Ke Liu; Yinlian Pan; Xing Du
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

9.  A Guidance for Concomitant Drug Reconciliation Prior to Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults.

Authors:  Beth Apsel Winger; Susie E Long; Jordan Brooks; Ashish O Gupta; Christopher C Dvorak; Janel Renee Long-Boyle
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.